THYMOSIN ALPHA-1

THYMOSIN ALPHA-1 (TA1)

Thymosin Alpha-1 (TA1) is a synthetic version of a naturally occurring 28-amino-acid peptide originally identified in the thymus. It has been extensively studied for its immunomodulatory properties, particularly its ability to influence innate and adaptive immune responses.

TA1 interacts with several components of the immune system, including T cells, dendritic cells, macrophages, and natural killer (NK) cells. Rather than simply stimulating the immune system, TA1 is thought to help modulate immune responses according to the body's needs, which has made it a subject of research in infectious diseases, immune dysfunction, vaccine response, and inflammatory conditions.

Key Benefits

• Supports healthy T-cell and NK-cell activity

• Supports balanced innate and adaptive immune responses

• May enhance immune responsiveness during certain infections

• Has been studied as an adjunct to selected antiviral treatment protocols

•  May support immune recovery during periods of physiological stress

• May enhance immune response to vaccination in selected populations

• Supports antioxidant and cellular-defense pathways

• May contribute to tissue-repair and recovery processes

• Has been investigated as an adjunct in certain oncology protocols

Important: TA1 is an immunomodulatory peptide and should not be represented as a treatment or cure for infections, cancer, HIV, hepatitis, or other diseases without appropriate medical supervision.

Mechanism of Action

TA1 acts on multiple components of the immune system. It has been studied for its ability to enhance antigen presentation, support T-cell maturation and function, and modulate dendritic-cell and NK-cell activity.

TA1 may also influence signaling pathways involved in innate immunity and cytokine regulation. Its effects are generally described as immunomodulatory rather than simply immune-stimulating, which may allow it to support appropriate immune responses while helping regulate excessive inflammatory signaling.

Who May Benefit from TA1 Research

TA1 has been investigated in individuals with:

• Compromised or dysregulated immune responses

• Certain acute or chronic infections

• Reduced immune responsiveness associated with aging

• Situations where enhanced vaccine response is being evaluated

• Selected oncology-support protocols under medical supervision

Because individual immune conditions vary considerably, TA1 should be used under appropriate healthcare supervision when being considered for a medical indication.

Possible Side Effects

TA1 is generally reported to be well tolerated, but possible effects may include:

• Injection-site redness, swelling, itching, or discomfort

• Headache

• Fatigue

• Fever or flu-like symptoms

• Muscle or joint aches

• Nausea

• Dizziness

Most reported reactions are mild and temporary. Discontinue use and seek medical attention if signs of a significant allergic or systemic reaction occur.

Warnings and Precautions

Use caution and seek medical guidance if you have:

• An autoimmune or immune-mediated disorder

• A history of severe allergic reactions

• An active infection requiring medical treatment

• A history of malignancy or are undergoing cancer treatment

• Significant liver or kidney impairment

• A condition requiring immunosuppressive medication

TA1 may influence immune signaling and should not be used as a substitute for prescribed antimicrobial, antiviral, immunosuppressive, or cancer therapy.

Individuals receiving immunomodulatory or immunosuppressive medications should discuss potential interactions with a qualified healthcare professional before use.

Contraindications

Do not use TA1 if:

• You are pregnant or breastfeeding, unless specifically advised by a qualified healthcare professional

• You have a known hypersensitivity to TA1 or any formulation component

• You have experienced a previous serious reaction to the product

• You are undergoing treatment for a serious immune-related condition without appropriate medical supervision

Safety data for pediatric use are limited; use in children should only occur under specialist medical supervision.

Reconstitution and Dosing

Reconstitution:

• Mix Thymosin Alpha-1 10mg with 2mL (200 units) of Bacteriostatic Water (BAC Water).

Dosing example from Research:

• 32 units (1.6 mg) 2×/week (3-4 days apart)

Cycle example from Research: 

• 4 - 24 weeks ON → 2 - 12 weeks OFF

Important Notes:

Because TA1 is a prescription/research compound with different dosing regimens used in clinical studies,  and dosing should be determined by a qualified healthcare professional according to the intended medical indication, patient characteristics, and applicable product guidance. Do not use the dosing examples from research studies as a universal personal dosing protocol.

Recommended Stacks

TA1 is sometimes discussed alongside other compounds in broader wellness or recovery protocols. Because combination safety has not been adequately established for many peptide combinations, concurrent use should be approached cautiously.

• NAD+ — Supports cellular energy metabolism and mitochondrial function.

• Glutathione — Provides antioxidant support and complements cellular-defense pathways.

• GHK-Cu — Studied for tissue repair, skin health, and regenerative pathways.

• BPC-157 / TB-500 — Investigated for tissue-repair and recovery mechanisms; human safety data for combination use remain limited.

• Epitalon — Investigated in longevity and cellular-aging research, although evidence for combination use with TA1 remains limited.

• CJC-1295 / Ipamorelin — Primarily studied for growth-hormone-related effects rather than immune modulation; combination use should be medically supervised.

Important: Stacking multiple biologically active peptides does not necessarily improve outcomes and may increase the potential for adverse effects or unpredictable interactions. Use combinations only with appropriate professional guidance.

Caveat / Disclaimer

• This guide is for educational purposes only and does not replace medical advice.

• Peptides in compounded form are not approved by the FDA or the Philippine DOH for safety, quality, or effectiveness.

• All medications carry risks. Side effects, allergic reactions, or complications may occur.

• Only a licensed healthcare professional can decide if these peptides are safe for you.

• Do not use if you have medical condition or without medical supervision.

• By using these products, you accept that it is provided “as is”, with no guarantee of results, safety, or effectiveness.

• LUMI+ PEPTIDES PH is not responsible for any misuse, side effects, or complications.